XML 26 R15.htm IDEA: XBRL DOCUMENT v3.26.1

Goodwill and Intangible Assets, Net

3 Months Ended

Jun. 30, 2026

Intangible Asset, Goodwill and Other [Abstract]

Goodwill and Intangible Assets, Net

Goodwill and Intangible Assets, Net

Goodwill

The Company evaluates goodwill for impairment on an annual basis in the first fiscal quarter, and more frequently if indicators for potential impairment exist. Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit. The annual impairment testing performed in fiscal 2027 and fiscal 2026 did not indicate any impairment of goodwill.

Changes in the carrying amount of goodwill were as follows:

(In millions)			North American Pharmaceutical						Oncology & Multispecialty						Prescription Technology Solutions						Medical-Surgical Solutions												Total
Balance, March 31, 2026			$	2,781					$	3,963					$	2,065					$	2,507											$	11,316
Goodwill acquired			—						13						—						—												13
Disposals			—						(2)						—						—												(2)
Foreign currency translation adjustments, net			(26)						—						—						—												(26)
Other adjustments (1)			—						(23)						—						—												(23)
Balance, June 30, 2026			$	2,755					$	3,951					$	2,065					$	2,507											$	11,278

(1)Reflects acquisition-related goodwill adjustments.

Intangible Assets

Information regarding intangible assets was as follows:

			June 30, 2026																								March 31, 2026
(Dollars in millions)			Weighted- Average Remaining Amortization Period (Years)						Gross Carrying Amount						Accumulated Amortization						Net Carrying Amount						Gross Carrying Amount						Accumulated Amortization						Net Carrying Amount
Customer relationships			9						$	1,475					$	(738)					$	737					$	1,477					$	(717)					$	760
Service agreements			23						3,181						(803)						2,378						3,249						(833)						2,416
Trademarks and trade names			19						574						(295)						279						576						(293)						283
Provider Networks			21						393						(20)						373						383						(15)						368
Technology			8						317						(165)						152						317						(160)						157
Other			21						127						(33)						94						127						(32)						95
Total									$	6,067					$	(2,054)					$	4,013					$	6,129					$	(2,050)					$	4,079

All intangible assets were subject to amortization as of June 30, 2026 and March 31, 2026. Amortization expense of intangible assets was $74 million and $50 million for the three months ended June 30, 2026 and 2025, respectively.

Estimated amortization expense of the assets listed in the table above is as follows:

(In millions)						Estimated Amortization Expense
Fiscal 2027 (from July 1, 2026 to March 31, 2027)						$	213
Fiscal 2028						279
Fiscal 2029						275
Fiscal 2030						272
Fiscal 2031						264
Thereafter						2,710

X

- References

No definition available.

+ Details

Name:	us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for intangible asset and goodwill. Includes, but is not limited to, finite- and indefinite-lived intangible assets, capitalized cost for internal-use software and software to be sold, leased, or marketed.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/350-30/tableOfContent

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/350-20/tableOfContent

+ Details

Name:	us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration